Design and Synthesis of Pyrazoline Derivatives as Anti-inflammatory Agents

The study involved the synthesis and evaluation of several derivatives of 4-(5-phenyl-1H-pyrazol-3-yl) phenol to determine their biological activity. The spectrum analysis validated the structural alterations made to improve the pharmacological characteristics. The compounds underwent molecular docking studies to forecast their binding affinity with the 1B17 protein, a significant target for anti-inflammatory illnesses. The docking tests were conducted using Schrodinger software, and the findings revealed that many derivatives displayed substantial binding interactions with crucial active site residues of the 1B17 protein. An analysis was conducted on the binding modes, which uncovered significant H bonding and π-π stacking interactions, among others, that play a role in stabilizing the ligand-protein complex. Out of all the artificially created molecules, the derivative with the highest docking score was determined to be a potential contender for further advancement. These findings indicate that derivatives of 4-(5-phenyl-1H-pyrazol-3-yl) phenol have the potential to be used as therapeutic drugs that target the 1B17 protein. Further biological evaluations should be conducted to study this